Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Taguchi

Showing results (971-980 of 978) with videos related to

Pageof 98
Sort By:
You have reached the last page of results.This site can display upto 978 results.
British Journal of Cancer|August 24, 2013
MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumoursC M M Gits, P F van Kuijk, M B E Jonkers, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 9, 1998
[Phase I study of S-1. S-1 Study Group]T Taguchi, Y Inuyama, R Kanamaru, et al.
Hinyokika Kiyo. Acta Urologica Japonica|February 1, 1996
[Phase I study of bicalutamide (Casodex), a nonsteroidal antiandrogen in patients with prostatic cancer]T Kotake, M Usami, S Isaka, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 3, 2019
Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodiesT Sakakida, T Ishikawa, Y Chihara, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2018
Metal-free class Ie ribonucleotide reductase from pathogens initiates catalysis with a tyrosine-derived dihydroxyphenylalanine radicalElizabeth J Blaesi, Gavin M Palowitch, Kai Hu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 13, 1999
[Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent head and neck cancer]Y Inuyama, A Kataura, K Togawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 8, 1998
[Phase I study of TAT-59 (a new antiestrogen) in breast cancer. TAT-59 Study Group]Y Nomura, O Abe, K Enomoto, et al.
Physical Review Letters|November 22, 2024
Laser-Driven Proton-Only Acceleration in a Multicomponent Near-Critical-Density PlasmaY Sakawa, H Ishihara, S N Ryazantsev, et al.
Pageof 98

Showing results (971-980 of 978) with videos related to

Sort By:
Pageof 98
You have reached the last page of results.This site can display upto 978 results.
British Journal of Cancer|August 24, 2013
MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumoursC M M Gits, P F van Kuijk, M B E Jonkers, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 9, 1998
[Phase I study of S-1. S-1 Study Group]T Taguchi, Y Inuyama, R Kanamaru, et al.
Hinyokika Kiyo. Acta Urologica Japonica|February 1, 1996
[Phase I study of bicalutamide (Casodex), a nonsteroidal antiandrogen in patients with prostatic cancer]T Kotake, M Usami, S Isaka, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 3, 2019
Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodiesT Sakakida, T Ishikawa, Y Chihara, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2018
Metal-free class Ie ribonucleotide reductase from pathogens initiates catalysis with a tyrosine-derived dihydroxyphenylalanine radicalElizabeth J Blaesi, Gavin M Palowitch, Kai Hu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 13, 1999
[Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent head and neck cancer]Y Inuyama, A Kataura, K Togawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 8, 1998
[Phase I study of TAT-59 (a new antiestrogen) in breast cancer. TAT-59 Study Group]Y Nomura, O Abe, K Enomoto, et al.
Physical Review Letters|November 22, 2024
Laser-Driven Proton-Only Acceleration in a Multicomponent Near-Critical-Density PlasmaY Sakawa, H Ishihara, S N Ryazantsev, et al.
Pageof 98